Literature DB >> 21904906

Urate nephropathy associated with impaired kinetic properties of hypoxanthine phosphoribosyl transferase in a 45-day-old infant.

Rashi Singal1, Sriram Krishnamurthy, Parameswaran Narayanan, Nachiappa Ganesh Rajesh, Bharat Choudhary, Gabriella Jacomelli, Vanna Micheli.   

Abstract

We report a 45-day-old male infant who presented with anuric renal failure and fluid overload due to urate nephropathy consequent upon hyperuricemia with hyperuricosuria. His maternal uncle had undergone renal transplantation for chronic renal failure secondary to uric acid nephrolithiasis. The levels of hypoxanthine phosphoribosyl transferase (HPRT) and adenine phosphoribosyl transferase activity in the baby were found to be quantitatively normal. However, when the HPRT activity was measured at low substrate concentrations [phosphoribosyl pyrophosphate (PRPP) and hypoxanthine] and compared with usual assay conditions, the HPRT activity at lower PRPP was less in the propositus, suggesting altered enzyme kinetics. Apparent K (m(PRPP)) and V (max), but not K (m(hypoxanthine)), were then found to be higher in the propositus than the control range. This is the first case of urate nephropathy secondary to altered enzyme kinetics presenting as early as 45 days. Uric acid nephropathy should be considered in the differential diagnosis of unexplained acute kidney injury in infants. In such cases, quantitative tests for HPRT enzyme activity may not be sufficient and altered enzyme kinetics should also be investigated.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21904906     DOI: 10.1007/s10157-011-0536-8

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  13 in total

1.  Uric acid nephropathy as an unusual cause of actual renal failure in a neonate.

Authors:  A Shenoi; K D Phadke
Journal:  Indian Pediatr       Date:  2000-03       Impact factor: 1.411

2.  Failure to thrive, hyperuricemia, and renal insufficiency in early infancy secondary to partial hypoxanthine-guanine phosphoribosyl transferase deficiency.

Authors:  W B Lorentz; B K Burton; A Trillo; M C Browning
Journal:  J Pediatr       Date:  1984-01       Impact factor: 4.406

3.  Involvement of macrophage migration inhibitory factor (MIF) in experimental uric acid nephropathy.

Authors:  Y G Kim; X R Huang; S Suga; M Mazzali; D Tang; C Metz; R Bucala; S Kivlighn; R J Johnson; H Y Lan
Journal:  Mol Med       Date:  2000-10       Impact factor: 6.354

4.  Renal uric acid clearance in human neonates.

Authors:  F B Stapleton
Journal:  J Pediatr       Date:  1983-08       Impact factor: 4.406

5.  Impaired kinetic properties of hypoxanthine-guanine phosphoribosyl transferase as a cause of uric acid nephropathy in early infancy.

Authors:  E Kerem; D Branski; E Gross-Kieselstein; H Hurvitz; A Abrahamov; Y Pollack
Journal:  Eur J Pediatr       Date:  1987-11       Impact factor: 3.183

6.  Lesch-Nyhan syndrome presenting with acute renal failure in a 3-day-old newborn.

Authors:  Ivana Pela; Maria Alice Donati; Elena Procopio; Patrizio Fiorini
Journal:  Pediatr Nephrol       Date:  2007-08-16       Impact factor: 3.714

7.  Renal failure in infancy due to over-production of urate.

Authors:  J A Batch; R P Riek; R B Gordon; J R Burke; B T Emmerson
Journal:  Aust N Z J Med       Date:  1984-12

8.  Sequence, expression and characterization of HPRTMoose Jaw: a point mutation resulting in cooperativity and decreased substrate affinities.

Authors:  T Lightfoot; R M Lewkonia; F F Snyder
Journal:  Hum Mol Genet       Date:  1994-08       Impact factor: 6.150

Review 9.  Could uric acid have a role in acute renal failure?

Authors:  A Ahsan Ejaz; Wei Mu; Duk-Hee Kang; Carlos Roncal; Yuri Y Sautin; George Henderson; Isabelle Tabah-Fisch; Birgit Keller; Thomas M Beaver; Takahiko Nakagawa; Richard J Johnson
Journal:  Clin J Am Soc Nephrol       Date:  2006-12-06       Impact factor: 8.237

Review 10.  Hypoxanthine-guanine phosophoribosyltransferase (HPRT) deficiency: Lesch-Nyhan syndrome.

Authors:  Rosa J Torres; Juan G Puig
Journal:  Orphanet J Rare Dis       Date:  2007-12-08       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.